510(k) · Cleared
ClearedLiquichek Ana Control, Centromere Pattern, Model 203
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Bio-Rad · DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Cleared on Dec 18, 1998 as substantially equivalent to K813592 (Kallestad Laboratories, Inc., 1982) after a 9-day review. Its family tree reaches back 1 generation to 1982. 2 later devices descend from it.
- Decided
- Dec 18, 1998
- Review
- 9 days
- Class
- Class II
- Product code
- DHN
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K813592 (1982). 2 later devices descend from it, 2 citing it directly.
- Root · 1 generation backK813592 Quantafluor Fluorescent Test ReagentsKallestad Laboratories, Inc. · 1982 · Recalled
- This deviceK984397 Liquichek Ana Control, Centromere Pattern, Model 203Bio-Rad · 1998
- Descendant · cites it directly · 0 of its ownK024230 Liquichek Ana Control Set, Positive: Homogeneous, Speckled…Bio-Rad · 2003
- Descendant · cites it directly · 0 of its ownK024222 Liquichek Ana Control Centromere Pattern, Positive, Catalog #112Bio-Rad · 2003
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K813592 | Quantafluor Fluorescent Test Reagents | Kallestad Laboratories, Inc. | 1982 | 2 |
| 0 (this device) | K984397 | Liquichek Ana Control, Centromere Pattern, Model 203 | Bio-Rad | 1998 | — |
| +1 | K024230 | Liquichek Ana Control Set, Positive: Homogeneous, Speckled, Centromere and… | Bio-Rad | 2003 | — |
| +1 | K024222 | Liquichek Ana Control Centromere Pattern, Positive, Catalog #112 | Bio-Rad | 2003 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2003 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DHN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K813592 | Quantafluor Fluorescent Test ReagentsSummary page 1…Antigen, Control. Devices to Which Substantial Equivalence is Claimed Kallestad Quantafluor Autoantibody Positive Control Sanofi Diagnostics Pasteur Chaska, Minnesota K813592 Statement of Iintended Use Liquichek ANA Control, Centromere Pattern is intended for use as an unassayed quality control to mon… | 1982 |
What descends from it? (2)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All DHN devicesDHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · DHN
1in 2022
2026 to Oct 25, outlined.
Median 510(k) review, days · DHN
Too few DHN 510(k)s in any year since 2007 to give a median.
Recalls per year · DHN
1in 2011
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · DHN
No MAUDE report names DHN since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 0 | — | 2 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 1 | 0 |
| 2011 | 0 | — | 1 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 2 | — | 0 | 0 |
| 2016 | 2 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 1 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Liquichek ANA Control, Centromere Pattern is intended for use as an
unassayed quality control to monitor indirect immunofluorescent testing of
antinuclear antibodies (ANA).
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K984397 · printed Nov 6, 2026
Cite this page
510(k) Report. “K984397: Liquichek Ana Control, Centromere Pattern, Model 203.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K984397
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026